OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Conventional and robotic automation inside closed systems reduces risk.
Evolving equipment designs meet the needs of continuous processing techniques.
Stability programs for biologics are far more complex than small-molecule drugs.
Reformulation strategies are useful tools for more than just stretching out return on investment.
Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.
Next Big COVID Challenge: Vaccines for Little Kids
Pharma strategizes to reduce its environmental footprint while optimizing output.
October 15, 2021
The council voted 19–0 to recommend that FDA authorize booster doses of the Moderna COVID-19 vaccine for certain populations.
In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.
MilliporeSigma announced the opening of its second Carlsbad, California-based facility, which doubles production capacity to support commercial and industrial manufacturing of viral vectors.
After months of deliberation, Biden plans to appoint cardiologist Robert Califf as FDA commissioner.
Back in person at the Javits Center, exhibitors present containers, components, equipment, and services to fill, ship, protect, and optimize the packaging process.
October 14, 2021
Aceto will acquire A&C Bio Buffer, including the company’s custom buffer and chemical blend portfolio.
Pharmalex has launched the Biopharma Excellence brand, a new service line that combines the expertise of PharmaLex, ERA Consulting, and Biopharma Excellence.
SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.
AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science.
This acquisition grants Bionano access to BioDiscovery’s clinical software solution for variant analysis.